CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.19 HKD | 0.00% |
|
-0.76% | +26.41% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 5.24B 725M 5.67B | Sales 2025 * | 6.06B 838M 6.55B | Capitalization | 6.42B 888M 6.94B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.13B 156M 1.22B | Net income 2025 * | 1.31B 181M 1.42B | EV / Sales 2024 * | 0.13 x |
| Net cash position 2024 * | 5.74B 794M 6.21B | Net cash position 2025 * | 6.22B 861M 6.73B | EV / Sales 2025 * | 0.03 x |
| P/E ratio 2024 * |
5.85
x | P/E ratio 2025 * |
5.05
x | Employees | 3,436 |
| Yield 2024 * |
6.67% | Yield 2025 * |
7.8% | Free-Float | 33.69% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -0.76% | ||
| Current month | -0.76% | ||
| 1 month | -7.17% | ||
| 3 months | +14.45% | ||
| 6 months | +28.71% | ||
| Current year | +26.41% |
1 week
8.90
9.48
1 month
8.9010.06
Current year
7.2210.72
1 year
6.5510.72
3 years
4.6310.72
5 years
4.6010.72
10 years
4.6018.54
| Managers | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
FOU | Founder | 68 | 02-08-13 |
King Kuen Hung
IRC | Investor Relations Contact | 58 | - |
Baochang Liu
SAM | Sales & Marketing | 44 | 19-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhen Jiang Li
FOU | Founder | 68 | 02-08-13 |
Wencheng Zhou
BRD | Director/Board Member | 48 | 20-09-30 |
Yun Xia Xin
FOU | Founder | 60 | 02-08-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 0 M€ | +3.22% | - | |
| 0.00% | 0 M€ | +3.45% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 9.19 | -0.43% | 369,000 |
| 24-05-07 | 9.23 | +0.98% | 954,000 |
| 24-05-06 | 9.14 | -1.72% | 1,527,000 |
| 24-05-03 | 9.3 | -0.53% | 826,000 |
| 24-05-02 | 9.35 | +0.97% | 304,000 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 04:08 am EDT
More quotes
China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Companyâs subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.
Sector
Pharmaceuticals
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.495
CNY
Average target price
13.01
CNY
Spread / Average Target
+53.16%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +26.41% | 891M | |
| +20.83% | 43.57B | |
| +20.70% | 22.7B | |
| +16.41% | 14.32B | |
| +11.11% | 13.42B | |
| +45.91% | 11.83B | |
| -8.84% | 6.98B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.41% | 5.51B |
- Stock Market
- Equities
- 2877 Stock